The study, called HVTN 702, aims to enroll 5,400 sexually active men
and women aged between 18 and 35 at 15 sites across South Africa.
It will be the largest and most advanced HIV
vaccine clinical trial to take place in South Africa, where more than
1,000 people a day are infected with HIV.
Click here for the full article.
No comments:
Post a Comment